CHAPTERS
- 0:00 – 3:01
Max’s origin story: his mom’s Lewy body dementia and “diagnose and adios” medicine
Max explains how his mother’s early symptoms (starting at 58) led him into dementia research and advocacy. He contrasts rushed, fragmented care with the Cleveland Clinic’s team-based approach that finally identified a neurodegenerative condition.
- •Max’s background in journalism/TV and longstanding interest in health
- •Mother’s diagnosis trajectory: early symptoms → Alzheimer’s/Parkinson’s meds → later Lewy body dementia
- •Frustration with superficial clinical encounters (“diagnose and adios”)
- •Cleveland Clinic as a turning point for comprehensive evaluation
- 3:01 – 3:31
Dementia starts decades early: turning fear into prevention mindset
Max describes the now-common view that dementia pathology begins 10–30 years before symptoms. That timeline reframes Alzheimer’s/dementia as, in many cases, something people can influence with earlier lifestyle and risk reduction strategies.
- •Dementia’s long preclinical phase as an empowering insight
- •Family history as a motivating risk signal
- •Using skepticism and investigation skills from journalism to read primary literature
- •Shift from inevitability to agency (“change our cognitive destiny”)
- 3:31 – 6:56
Building 'Little Empty Boxes': documentary work, research access, and clinical collaboration
Max outlines creating what he frames as an early documentary focused on dementia prevention, filming his mom while interviewing leading scientists. He also discusses joining a prevention study at Weill Cornell and collaborating with Richard Isaacson.
- •Documentary approach: personal story plus global research interviews
- •Becoming a research subject at Weill Cornell
- •Mentorship/collaboration with Richard Isaacson; co-authoring clinical prevention material
- •Film title meaning and partnership with Alzheimer’s Foundation of America
- 6:56 – 13:59
Genetics vs environment: ApoE4, modifiable risk, and the “Western lifestyle trigger”
Joe asks whether dementia is genetic; Max breaks down non-modifiable vs modifiable risk factors and focuses on ApoE4. He argues that environment and lifestyle heavily shape whether genetic vulnerability becomes disease.
- •Three non-modifiable risks: age, genes, gender; women’s higher risk
- •ApoE4 prevalence (~1 in 4) and increased vulnerability to brain insults (incl. TBI/CTE)
- •ApoE4 as ancestral allele; selection pressures tied to agriculture/sedentary life
- •Gene–environment interplay: risk in the U.S. vs attenuated association in less-industrialized settings (e.g., Ibadan, Nigeria)
- 13:59 – 18:50
Early brain changes: glucose hypometabolism, insulin resistance, and what testing can (and can’t) show
The conversation moves to what researchers can detect before symptoms—especially reduced brain glucose metabolism. Max connects this to whole-body insulin resistance and explains why PET scans aren’t routinely available clinically.
- •Alzheimer’s feature: reduced brain glucose metabolism detectable years earlier
- •FDG-PET as a research tool; limited clinical access
- •Insulin resistance as a practical correlate of brain energy impairment
- •Risk factor framing: diabetes and obesity as key modifiable levers
- 18:50 – 23:23
Lifestyle prevention toolkit: exercise, blood pressure control, and resistance vs cardio
Max emphasizes exercise as ‘medicine’ for the brain, highlighting blood flow, BDNF, inflammation reduction, and blood pressure improvements. He cites trials linking blood pressure treatment to lower mild cognitive impairment risk and discusses training modalities.
- •Exercise increases blood flow and BDNF (‘Miracle-Gro’ for the brain)
- •SPRINT MIND: aggressive BP control reduces mild cognitive impairment risk
- •Resistance training improves insulin sensitivity and glucose disposal via muscle mass
- •Cardio vs lifting: both matter; cardio has strong mechanistic evidence for BDNF
- 23:23 – 37:22
Alzheimer’s research scandal: amyloid hypothesis, fabricated data, and FDA approval controversy
They unpack reporting that a major 2006 Nature paper supporting the amyloid hypothesis may have used fabricated images/data. Max explains how amyloid dominated funding and drug development despite weak symptom correlation, culminating in controversial approvals.
- •Amyloid plaques as historic focus; weak correlation with cognitive symptoms
- •2006 Nature paper and the purported Aβ*56 ‘missing link’
- •Image sleuthing (PubPeer) and allegations of fabricated Western blots
- •Aducanumab (Aduhelm): plaque reduction without meaningful cognitive benefit; significant adverse events
- •Institutional inertia and sunk-cost dynamics; ‘amyloid mafia’ pressure and suppression of alternatives
- 37:22 – 43:02
Beyond amyloid: metabolic framing and ketogenic therapy as symptom support
Max argues that impaired brain glucose use is central, and that ketones remain usable in Alzheimer’s brains. He discusses ketogenic diets/therapies as a way to ‘keep the lights on,’ while noting the practical difficulty of dietary change in dementia patients.
- •Alzheimer’s brain: large reduction in glucose-based energy, ketone use preserved
- •Ketogenic diet as non-cure supportive therapy; evidence for functional gains in mild–moderate cases
- •Practical barriers: emerging sweet tooth and adherence challenges in dementia
- •Critique of symptom-only drugs (e.g., donepezil, memantine) and slow translation of prevention science
- 43:02 – 56:08
Nutrition detour: eggs, cholesterol, and Joe’s backyard chicken saga (and why yolks matter)
A discussion of cholesterol and vegan ideology leads into Joe’s extended story about raising chickens and their predatory behavior. Max frames eggs as a ‘cognitive multivitamin’ due to brain-building nutrients concentrated in yolks.
- •Joe critiques vegan ideology; proposes backyard eggs as an ethical compromise
- •Extended anecdote: chickens, coyotes, and chickens hunting mice
- •Egg yolk vs egg whites: choline, B12, and brain-relevant nutrients
- •Brain cholesterol facts: brain holds a large share of body cholesterol; dietary cholesterol vs endogenous synthesis
- 56:08 – 1:15:28
Seed oils vs olive oil: processing, oxidation, aldehydes, omega-6 balance, and buying/storing oils
Joe and Max dig into industrial seed oils (RBD oils) and their processing, heat instability, and oxidation byproducts. They contrast this with extra virgin olive oil’s stability and polyphenols, then give practical guidance for choosing and storing oils.
- •RBD oils (refined/bleached/deodorized) and why deodorization matters
- •High-heat cooking: aldehydes (e.g., acrolein) and other oxidation products
- •Omega-6 overconsumption and modern omega-6:omega-3 imbalance
- •Extra virgin olive oil as evidence-supported staple; oleocanthal’s ibuprofen-like anti-inflammatory effect
- •Shopping tips: small dark glass bottles, harvest date, keep away from heat/light; filtered vs unfiltered
- 1:15:28 – 1:24:53
Greens, fiber, and gut resilience: oxalates, ‘plant toxins,’ microbiome adaptation, and carnivore as therapeutic
Max defends vegetables and fiber while acknowledging individual tolerances and gut dysbiosis. They discuss oxalates and kidney stones, cooking vs raw tradeoffs, and why abrupt fiber increases can cause GI symptoms; carnivore diets are framed as short-term tools for some.
- •Daily leafy greens associated with ‘younger’ cognitive performance in observational studies
- •Carotenoids (lutein/zeaxanthin): cognitive/visual processing benefits; fat improves absorption
- •Oxalates: mainly a concern for susceptible individuals; spinach as higher-oxalate example
- •Fiber and microbiome: adaptation period; bloating when intake changes too fast
- •Plant defense compounds as hormetic stressors; carnivore as elimination/therapeutic approach for some
- 1:24:53 – 1:34:51
Heat and cold for brain health: sauna dose-response, protocols, and Finnish data vs healthy-user bias
They explore sauna research—especially from Finland—linking frequency with large dementia risk reductions, while discussing the importance of dose and recovery. Joe details his own sauna/cold plunge routine and the interplay of acclimation and protocol sequencing.
- •Sauna frequency correlations: 2–3x/week vs 4–7x/week and dementia risk reduction
- •Temperature/duration nuance: high temperatures may reverse benefits
- •Joe’s protocol: sauna, cold plunge cycles, and ending cold
- •Sauna as an aerobic ‘mimetic’ and blood-pressure support
- •Why Finnish data helps reduce ‘healthy user bias’ confounding
- 1:34:51 – 1:55:27
Hidden performance killer: antiseptic mouthwash, nitric oxide pathway, diabetes/hypertension risk, and fluoride alternatives
Max argues that frequent antiseptic mouthwash disrupts oral bacteria needed to convert dietary nitrates into nitric oxide, blunting exercise benefits and potentially worsening metabolic health. The discussion expands to fluoride, endocrine disruption, and hydroxyapatite toothpaste as an alternative.
- •Oral bacteria convert nitrates → nitrites → nitric oxide; impacts blood flow/BP
- •Antiseptic mouthwash post-workout can reduce exercise BP-lowering benefits
- •Observational links: frequent antiseptic mouthwash use associated with higher diabetes and hypertension risk
- •Fluoride concerns (bactericidal + potential endocrine disruption); dose-response complexity
- •Hydroxyapatite toothpaste as a fluoride alternative; practical oral-health basics
- 1:55:27 – 2:10:31
Agricultural chemicals and system tradeoffs: glyphosate exposure, organics, GMOs, scalability, and declining plant nutrition
Joe raises glyphosate prevalence and debates food-system realities: monocrop efficiency vs toxin exposure and regenerative agriculture scalability. Max discusses organic tradeoffs, reduced cadmium findings, and how CO₂ and soil depletion may be lowering nutrient density in modern produce.
- •Glyphosate found broadly in biomonitoring; concerns about endocrine and microbiome effects
- •Organic vs conventional: similar micronutrients, but potential reductions in pesticide/heavy metal exposure; higher plant defense compounds
- •GMO crops and heavy spraying tolerance; precautionary principle framing
- •Scalability challenges of regenerative/organic at national scale; personal vs global optimization
- •‘Ionomic’ nutrient decline in produce; CO₂-driven starch increase/protein dilution; implications for population health
- 2:10:31 – 2:45:22
Diet, cholesterol narratives, and full-fat dairy: revisiting orthodox advice and what Max thinks matters most
They close by critiquing dietary guideline conflicts of interest, the legacy of sugar-industry influence, and simplistic ‘good vs bad cholesterol’ messaging. Max makes a nuanced case for nutrient-dense animal foods, discusses dairy’s benefits, and explains why butter may affect lipids differently than cream due to milkfat globule membrane disruption.
- •Critique of guideline-making conflicts of interest and ultra-processed food favoritism
- •Sugar industry influence and the saturated-fat scapegoat narrative
- •LDL/HDL nuance: HDL as marker vs cause; saturated fats differ (e.g., stearic acid)
- •Full-fat dairy associations with better cardiometabolic outcomes; low-fat often ultra-processed + sugary
- •Milkfat globule membrane: cream vs butter differing effects on LDL; butter as ‘indulgence’ for some
- •Max’s personal motivation and message: prevention-focused, non-dogmatic, science literacy
